Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC
Herein, we showcase the potential of plasma EV-derived <i>miR-29a-3p</i> as a prognostic biomarker and underscore the intricate interplay of miRNAs, lncRNAs, and metabolites in NSCLC biology. Our findings offer new insights and avenues for further exploration, contributing to the ongoing quest for effective biomarkers in early-stage NSCLC.
Authors
- Sotiris Ouzounis (ORCID: https://orcid.org/0000-0001-7541-6885)
- Θεοδώρα Κάτσιλα (ORCID: https://orcid.org/0000-0002-6263-4231)
- Evi Lianidou (ORCID: https://orcid.org/0000-0002-7796-5914)
- Vassilis Georgoulias (ORCID: https://orcid.org/0000-0003-2218-2522)
- Vivi Bafiti (ORCID: https://orcid.org/0000-0002-7811-3764)
- Athina Markou (ORCID: https://orcid.org/0000-0001-7760-9701)
- Αthanasios Kotsakis (ORCID: https://orcid.org/0000-0002-5530-6774)
- Eleni Thanou (ORCID: https://orcid.org/0009-0003-5555-3630)
Institutions
- National and Kapodistrian University of Athens (GR)
- University Hospital of Larissa (GR)
- National Hellenic Research Foundation (GR)
- Metropolitan Hospital (GR)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-05
- DOI
- https://doi.org/10.3390/cancers16223729
- Citations
- 4
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.94